Apotex Corp.

We are excited to participate at CPHI 2024 in Milan, the largest global marketplace where the pharma community comes to source new partners, showcase products and solutions, and make connections. If you are attending, be sure to visit the Apotex booth at location 22A56 to speak with our team including: Barry Fishman, Chief Corporate Development Officer Christine Baeder, President, Apotex USA Pradeep Sanghvi, Executive Vice President, R&D Kiran Krishnan, SVP, Global Regulatory & Medical Affairs Michael Bohling, VP, Sales and Marketing. #CPHI2024 #CPHIMilan #PharmaInnovation #Pharmaceuticals

As we welcome the Jewish New Year, Rosh Hashanah, we reflect on the past year. This is a time for healing, renewal, and hope. At Apotex, we are grateful for our community, partners, and colleagues who have been part of our journey. May this Rosh Hashanah bring you and your loved ones a sweet new year. #RoshHashanah #ShanaTova

?? Exciting news! ?? We are proud to announce that Apotex has been certified as a Great Place to Work? in the United States, Canada, and India! This recognition, as we mark our 50th anniversary, reflects our team’s dedication to fostering a supportive and inclusive workplace. Thank you to all our team members for making Apotex a great place to work. Together, we will continue to build a culture of excellence, teamwork, and innovation. More: https://lnkd.in/gQVR7M9Y #GreatPlaceToWork #USA #EmployeeEngagement #ApotexUS #50YearsOfExcellenceMore:

Our institutional sales team recently participated in the Vizient Connections Summit 2024 in Las Vegas, which provided the opportunity to connect with healthcare industry experts and learn more about emerging trends. A highlight was seeing our newest Apotex Corp. team member, Nick Gerebi, Senior Director, Institutional Sales, at this event along with Ken Greenwald, Director, Institutional IDN Sales. Nick brings more than 30 years of experience in institutional sales within the generic pharmaceutical sector. We’re excited to have him on board! #VizientConnections #HealthcareLeadership #FutureOfHealthcare

We are proud to be the first generic pharmaceutical manufacturer to launch oxcarbazepine ER and dasatinib tablets in the United States, delivering best-in-class launches that support patients on their journey to health. Learn more: https://shorturl.at/DDVWO https://shorturl.at/wY2ZO

We are proud to advance excellence in pharmacy education and support the future of pharmacy through our internships and sponsorships at Nova Southeastern University- College of Pharmacy. Recently, our team had the honor of attending the Nova Southeastern University College of Pharmacy White Coat Ceremony. This event celebrates students’ dedication to the profession and their academic journeys. For the past eight years, we have proudly sponsored this ceremony, reaffirming our dedication to nurturing the next generation of pharmacists. #pharmacy

We had a great time at the 2024 National Association of Chain Drug Stores (NACDS) Total Store Expo in Boston, MA. Our team enjoyed meeting industry partners, including pharmacy professionals, retailers, and suppliers, at this highly engaging and vibrant event.

We are honored to be recognized as a winner of Premier Inc.’s 2024 Supplier Horizon Award for providing Premier Inc. members with the highest levels of partnership, customer service, value creation, clinical excellence, and a commitment to lower costs. Apotex is excited about our partnership and will continue delivering top-value products and services to improve patient care.

HDA - Healthcare Distribution Alliance's Distribution Industry Award for Notable Achievements in Healthcare (DIANA) is one of the most distinguished awards in the pharmaceutical distribution industry, honoring pharmaceutical and consumer manufacturers for developing new and innovative products and promotions for the #healthcare distribution industry. Additionally, the awards recognize manufacturers' commitment to advancing #supplychain best practices through the organization's participation in HDA. We are pleased to share that Apotex Corp. received a DIANA award for being the First Merit Finalist in the?Best Overall Generic Pharmaceutical Product Manufacturer category with over $100 million in sales to healthcare distributors. This award is a testament to our unwavering focus on innovation and ongoing commitment to improving patient access nationwide.

Fifty years ago today, on May 24, 1974, Apotex was officially incorporated by our founder, Dr. Barry Sherman, marking the start of a remarkable journey. From its humble beginnings with just two employees to the iconic organization it is today, Apotex's growth and achievements have been nothing short of extraordinary. Over the last five decades, Apotex has consistently advocated for improved access to affordable medicine, building a solid foundation rooted in positively impacting the patient's journey to health. The company's remarkable 50-year history exemplifies innovation, from leading the way with #biosimilars in Canada to launching complex products in the United States and other key international markets. Additionally, Apotex's global footprint is enhanced through robust commercial infrastructure and strategic expansions that underscore its commitment to patient access. Today, on our 50th anniversary, we are proud to be the largest Canadian-based #pharmaceutical company, represented by our top position in the number of prescriptions produced, diverse portfolio of products, and our significant and complex manufacturing capabilities. In looking to the future, we reaffirm our commitment of the last 50 years to increase access to #innovative medicines and health products through a renewed strategic focus to serve patients at every step along their journey to health. #Apotexat50